Germline RTEL1 Variants in Telomere Biology Disorders
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63882 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Ashley S Thompson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA. Hauptthemen laut MEDLINE: DNA Helicases, Dyskeratosis Congenita, Germ-Line Mutation, Telomere. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Division of Cancer Epidemiology and Genetics.
Abstract (Originalsprache)
Rare germline variation in regulator of telomere elongation helicase 1 (RTEL1) is associated with telomere biology disorders (TBDs). Biallelic RTEL1 variants result in childhood onset dyskeratosis congenita and Hoyeraal‐Hreidarsson syndrome whereas heterozygous individuals usually present later in life with pulmonary fibrosis or bone marrow failure. We compiled all TBD‐associated RTEL1 variants in the literature and assessed phenotypes and outcomes of 44 individuals from 14 families with mono‐ or biallelic RTEL1 variants enrolled in clinical trial NCT00027274. Variants were classified by adapting ACMG‐AMP guidelines using clinical information, telomere length, and variant allele frequency data. Compared with heterozygotes, individuals with biallelic RTEL1 variants had an earlier age at diagnosis (median age 35.5 vs. 5.1 years, p < 0.01) and worse overall survival (median age 66.5 vs. 22.9 years, p < 0.001). There were 257 unique RTEL1 variants reported in 47 publications, and 209 had a gnomAD minor allele frequency
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.
- Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Sharon A Savage
Förderung
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Division of Cancer Epidemiology and Genetics
Zitieren
APA
Thompson, A. S., Niewisch, M. R., Giri, N., McReynolds, L. J., & Savage, S. A. (2025). Germline RTEL1 Variants in Telomere Biology Disorders. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63882
Vancouver
Thompson AS, Niewisch MR, Giri N, McReynolds LJ, Savage SA. Germline RTEL1 Variants in Telomere Biology Disorders. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63882
BibTeX
@article{Thompson2025,
author = {Thompson, Ashley S and Niewisch, Marena R and Giri, Neelam and McReynolds, Lisa J and Savage, Sharon A},
title = {Germline RTEL1 Variants in Telomere Biology Disorders},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63882}
}
EUVIMED